Search - tctmd.com

Displaying 141 - 160 of 164

Sort: Relevancy | Date

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Partner Content

Registration: TAVR Evolves: Are You and the Heart Team Ready?

July 7, 2017

TAVR Evolves: Are You and the Heart Team Ready?

CME

TAVR Evolves: Are You and the Heart Team Ready?

Partner Content

Registration: Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

July 7, 2017

Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

CME

Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

Partner Content

Registration: What’s Next for Left Main PCI?

April 7, 2017

What’s Next for Left Main PCI?

CME

What’s Next for Left Main PCI?

Partner Content

Registration: The Latest Data on Left Main Stenting and its Implications

March 13, 2017

Latest Data on Left Main Stenting and its Implications

CME

Latest Data on Left Main Stenting and its Implications

Expanded TAVR Indications: Post TCT 2016

CME

Expanded TAVR Indications: Post TCT 2016

Partner Content

Registration: Expanded TAVR Indications: Post TCT 2016

February 1, 2017

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

CME

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

CME

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

Key Design Criteria For True Next Generation DES

CME

Key Design Criteria For True Next Generation DES

Partner Content

CME Landing Page

November 22, 2016

Partner Content

Registration: A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

November 21, 2016

Partner Content

Registration: TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

November 21, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.